FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to oncology. Alloxan is injected intraperitoneally in female white outbred rats in dose of 15 mg/100 g of body weight. After 24 hours, the animals into the lumen of the right uterine horn using an intravenous catheter with an injection port of 22G, 0.9×25 mm, 0.5 ml of a tumour suspension of Guerin carcinoma is introduced in amount of (2.5-3.5)×106 cells. After insertion, the uterine horn is ligatured.
EFFECT: method enables to reproduce the Guerin carcinoma model developing with underlying diabetes mellitus, which in turn makes it possible to study the pathogenesis of the malignant process and the effect of the comorbid pathology on it, as well as to search for targets for the targeted therapy.
1 cl, 1 ex, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR STIMULATING HEMATOGENOUS DISSEMINATION OF CARCINOMA IN EXPERIMENT | 2021 |
|
RU2757676C1 |
METHOD FOR CREATING ORTHOTOPIC ENDOMETRIAL CANCER MODEL | 2024 |
|
RU2818464C1 |
METHOD OF PREDICTING RISK OF EARLY RECURRENCE OF ENDOMETRIAL SQUAMOUS CELL CARCINOMA IN PATIENTS WITH STAGE I OF DISEASE | 2023 |
|
RU2812609C1 |
A METHOD FOR MODELING THE PRIMARY MULTIPLE GROWTH OF MALIGNANT TUMORS WITH THE SUPPRESSION OF ONE TUMOR BY ANOTHER IN THE CONDITIONS OF PRIMARY IMMUNODEFICIENCY | 2021 |
|
RU2750127C1 |
METHOD OF CREATING MODEL OF UTERINE SARCOMA | 2024 |
|
RU2820404C1 |
METHOD FOR PREDICTION OF THE PATHOLOGICAL PROCESS IN UTERINE BODY CANCER | 2019 |
|
RU2712307C1 |
METHOD FOR CREATING AN EXPERIMENTAL MODEL OF TUMOR GROWTH IN CONDITIONS OF HYPOTHYROIDISM | 2021 |
|
RU2779358C1 |
METHOD FOR ASSESSING ENDOMETRIAL CANCER PROGRESSION IN PATIENTS WITH HYPERPLASTIC PROCESSES IN ENDOMETRIUM | 2014 |
|
RU2554505C1 |
METHOD FOR ENHANCING THE GROWTH OF B16/F10 MELANOMA VERSUS THE GROWTH OF B16/F10 MELANOMA WITH SELF-GRAFTING AND SLOWING THE GROWTH OF LLC (LEWIS CARCINOMA) VERSUS THE GROWTH OF LLC WITH SELF-GRAFTING IN CASE OF MULTIPLE PRIMARY MALIGNANT TUMORS AGAINST THE BACKGROUND OF PRIMARY IMMUNODEFICIENCY | 2021 |
|
RU2759487C1 |
METHOD FOR PREOPERATIVE PREDICTION OF THE RISK OF RECURRENCE IN PATIENTS WITH STAGE T1 ENDOMETRIAL CANCER | 2021 |
|
RU2762493C1 |
Authors
Dates
2025-01-14—Published
2024-07-26—Filed